全文获取类型
收费全文 | 5436747篇 |
免费 | 416748篇 |
国内免费 | 16330篇 |
专业分类
耳鼻咽喉 | 76509篇 |
儿科学 | 175479篇 |
妇产科学 | 147598篇 |
基础医学 | 804865篇 |
口腔科学 | 153427篇 |
临床医学 | 506024篇 |
内科学 | 993736篇 |
皮肤病学 | 127909篇 |
神经病学 | 450542篇 |
特种医学 | 210140篇 |
外国民族医学 | 1332篇 |
外科学 | 807526篇 |
综合类 | 152626篇 |
现状与发展 | 25篇 |
一般理论 | 3112篇 |
预防医学 | 456668篇 |
眼科学 | 129671篇 |
药学 | 387665篇 |
28篇 | |
中国医学 | 14251篇 |
肿瘤学 | 270692篇 |
出版年
2021年 | 57396篇 |
2019年 | 59710篇 |
2018年 | 77642篇 |
2017年 | 59745篇 |
2016年 | 66197篇 |
2015年 | 78119篇 |
2014年 | 112623篇 |
2013年 | 178448篇 |
2012年 | 157472篇 |
2011年 | 168691篇 |
2010年 | 135965篇 |
2009年 | 134245篇 |
2008年 | 153550篇 |
2007年 | 165816篇 |
2006年 | 171715篇 |
2005年 | 166181篇 |
2004年 | 166009篇 |
2003年 | 155244篇 |
2002年 | 143989篇 |
2001年 | 218040篇 |
2000年 | 215700篇 |
1999年 | 191603篇 |
1998年 | 78241篇 |
1997年 | 72282篇 |
1996年 | 70336篇 |
1995年 | 65742篇 |
1994年 | 59731篇 |
1993年 | 55260篇 |
1992年 | 142092篇 |
1991年 | 136860篇 |
1990年 | 132173篇 |
1989年 | 128388篇 |
1988年 | 118570篇 |
1987年 | 116313篇 |
1986年 | 109877篇 |
1985年 | 106719篇 |
1984年 | 85681篇 |
1983年 | 75209篇 |
1982年 | 54364篇 |
1981年 | 50101篇 |
1980年 | 46978篇 |
1979年 | 76149篇 |
1978年 | 58908篇 |
1977年 | 51321篇 |
1976年 | 47732篇 |
1975年 | 49169篇 |
1974年 | 55992篇 |
1973年 | 54121篇 |
1972年 | 51082篇 |
1971年 | 47434篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
981.
982.
James L. Dorling Alice E. Thackray James A. King Andrea Pucci Fernanda R. Goltz Rachel L. Batterham David J. Stensel 《Nutrients》2020,12(12)
The fat mass and obesity-associated gene (FTO) rs9939609 A-allele is linked to obesity and dyslipidemia, yet the independent influence of this polymorphism on blood lipids remains equivocal. We examined the influence of the FTO rs9939609 polymorphism on fasting and postprandial blood lipids in individuals homozygous for the risk A-allele or T-allele with similar anthropometric and demographic characteristics. 12 AA and 12 TT males consumed a standardized meal after fasting overnight. Blood samples were collected at baseline (−1.5 h), before the meal (0 h), and for five hours postprandially to measure lipid, glucose, and insulin concentrations. Time-averaged total area under the curve (TAUC) values (0–5 h) were calculated and compared between genotypes. Fasting triacylglycerol (TG), high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, total cholesterol, non-esterified fatty acid (NEFA), glucose, and insulin concentrations were similar between groups (p ≥ 0.293). TAUC for TG was similar in AAs and TTs (95% confidence interval (CI) −0.52 to 0.31 mmol/L/h; p = 0.606). Likewise, TAUC values were similar for NEFA (95% CI −0.04 to 0.03 mmol/L/h; p = 0.734), glucose (95% CI −0.41 to 0.44 mmol/L/h; p = 0.951), and insulin (95% CI −6.87 to 2.83 pmol/L/h; p = 0.395). Blood lipids are not influenced by the FTO rs9939609 polymorphism, suggesting the FTO-dyslipidemia link is mediated by adiposity and weight management is important in preventing FTO-related lipid variations. 相似文献
983.
984.
985.
Renal Denervation for Treatment of Cardiac Arrhythmias: State of the Art and Future Directions
下载免费PDF全文
![点击此处可从《Journal of cardiovascular electrophysiology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
JEDRZEJ KOSIUK M.D. SEBASTIAN HILBERT M.D. EVGENY POKUSHALOV M.D. GERHARD HINDRICKS M.D. Ph.D. JONATHAN S. STEINBERG M.D. ANDREAS BOLLMANN M.D. Ph.D. 《Journal of cardiovascular electrophysiology》2015,26(2):233-238
Renal Denervation for Treatment of Cardiac Arrhythmias . It has now been more than a quarter of a century since modulation of the sympathetic nervous system was proposed for the treatment of cardiac arrhythmias of different origins. But it has also been some time since some of the early surgical attempts have been abandoned. With the development of ablation techniques, however, new approaches and targets have been recently introduced that have revolutionized our way of thinking about sympathetic modulation. Renal nerve ablation technology is now being successfully used for the treatment of resistant hypertension, but the indication spectrum might broaden and new therapeutic options might arise in the near future. This review focuses on the possible impact of renal sympathetic system modulation on cardiac arrhythmias, the current evidence supporting this approach, and the ongoing trials of this method in electrophysiological laboratories. We will discuss the potential roles that sympathetic modulation may play in the future. 相似文献
986.
987.
988.
Jennifer Wang Jonathan G. Stine Scott L. Cornella Curtis K. Argo Steven M. Cohn 《临床与转化肝病杂志(英文版)》2015,3(4):254-259
Background and Aims: Gastric antral vascular ectasia (GAVE) is commonly found in patients with cirrhosis, but it is also associated with other diseases in the absence of cirrhosis. Whether GAVE confers a different severity of gastrointestinal (GI) bleeding between patients with and without cirrhosis remains unknown. We aim to examine whether there is a difference in clinically significant GI bleeding due to GAVE in patients with or without cirrhosis. Methods: This is a retrospective case-control study of patients who were diagnosed with GAVE between January 2000 and June 2014. Patients were categorized into cirrhosis and noncirrhosis groups, and those with an additional GI bleeding source were excluded. Univariate comparisons and multivariable models were constructed using logistic regression. Results: In total, 110 patients diagnosed with GAVE on esophagogastroduodenoscopy (EGD) were included in our analysis; 84 patients had cirrhosis (76.4%) and 26 (23.6%) did not. Active GI bleeding was more prevalent in patients without cirrhosis (63.4% vs. 32.1%, p=0.003) despite similar indications for EGD, and endoscopic treatment with argon plasma coagulation (APC) was required more often in this group, approaching statistical significance (27% vs. 10.7%, p=0.056). There was no difference in bleeding severity, as evidenced by similar re-bleeding rates, surgery, or death attributed to uncontrolled bleeding. The strongest independent risk factor for GI bleeding was the absence of cirrhosis (odds ratio (OR): 5.151 (95% confidence interval (CI): 1.08-24.48, p=0.039). Conclusions: Patients with GAVE in the absence of cirrhosis are at higher risk for active GI bleeding and require more frequent endoscopic treatment than similar patients with cirrhosis. It may be worthwhile to treat GAVE in this population even in the absence of active bleeding. 相似文献
989.
990.